Four-year gut disease treatment trial seeks lasting relief

NCT ID NCT05177835

Summary

This study follows people with moderate to severe ulcerative colitis who are already taking the experimental drug ABX464. It aims to check the long-term safety and effectiveness of taking 25mg of ABX464 once daily for up to 54 months. The research will monitor patients for side effects and track whether their symptoms and gut inflammation stay under control over several years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Antwerp University Hospital

    Antwerp, Belgium

  • CHU Nantes - Hôtel Dieu

    Nantes, France

  • CHU Saint Etienne - Hôpital Nord

    Saint-Etienne, France

  • Centre Hospitalier Universitaire De Montpellier

    Montpellier, France

  • Centre Hospitalier Universitaire Grenoble Alpes

    Grenoble, France

  • Centro Medico Teknon

    Barcelona, Spain

  • Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska

    Wroclaw, Poland

  • Centrum Medyczne Oporow

    Wroclaw, Poland

  • Centrum Medyczne Plejady

    Krakow, Poland

  • Cliniq s.r.o.

    Bratislava, Slovakia

  • Communal non-commercial enterprise "Cherkasy Regional Hospital of Cherkasy regional council"

    Cherkasy, Ukraine

  • Communal non-commercial enterprise "Khmelnytska Regional Hospital" of Khmelnytskiy regional council

    Khmelnytskyi, Ukraine

  • DRC Gyogyszervizsgalo Kozpont Kft.

    Balatonfüred, Hungary

  • Endomed s.r.o

    Vranov nad Topľou, Slovakia

  • Fakultni nemocnice u sv. Anny v Brne

    Brno, Czechia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, Italy

  • GASTRO I, s.r.o.

    Prešov, Slovakia

  • Goethe University Frankfurt

    Frankfurt, Germany

  • Győr-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház I. Belgyógyászat

    Győr, Hungary

  • Humanitas Mirasole S.p.A.

    Rozzano, Italy

  • IRCCS Ospedale Sacro Cuore Don Calabria

    Verona, Italy

  • Institut des MICI

    Neuilly-sur-Seine, France

  • Kliničko bolnički centar Zvezdara

    Belgrade, Serbia

  • LexMedica

    Wroclaw, Poland

  • Medical Network Sp. z o.o.

    Warsaw, Poland

  • Medical University of Vienna

    Vienna, Austria

  • Medicome Sp. z o. o.

    Oświęcim, Poland

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Medizinische Universitaet Innsbruck

    Innsbruck, Austria

  • Nemocnice Slany

    Slaný, Czechia

  • Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. i M. Nastaj sp. p

    Lublin, Poland

  • Opšta bolnica "Đorđe Joanović" Zrenjanin Odsek za gastroenterologiju

    Zrenjanin, Serbia

  • Ośrodek Badań Klinicznych "METABOLICA"

    Tarnów, Poland

  • Samodzielny PZOZ w Lecznej

    Łęczna, 21-010, Poland

  • Santa Sp. z o.o.

    Warsaw, Poland

  • Semmelweis University

    Budapest, Hungary

  • South Edmonton Gastroenterology

    Edmonton, Canada

  • Splosna Bolnisnica Murska Sobota

    Murska Sobota, Slovenia

  • Splošna bolnišnica Celje

    Celje, Slovenia

  • Studiengesellschaft BSF UG (haftungsbeschraenkt)

    Halle, Germany

  • Termedia Sp. z o.o (NSZOZ Termedica - Centrum Badan Klinicznych)

    Poznan, Poland

  • Trialmed CRS

    Piotrkow Trybunalski, Poland

  • UZ Leuven

    Leuven, Belgium

  • Univerzitetni klinični center Maribor

    Maribor, Slovenia

  • Vasutegeszseguegyi Nonprofit Koezhasznu Kft.

    Debrecen, Hungary

  • Wojskowy Szpital Kliniczny w Lublinie

    Lublin, Poland

Conditions

Explore the condition pages connected to this study.